May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
April 08, 2010
US Oftalmi has issued a nationwide voluntary recall of all its over-the-counter Camolyn eye drops and Fisiolin nasal drops in 15mL bottles due to conditions at the manufacturing facility that cannot assure the sterility of the products.
February 04, 2010
Lux Biosciences announced that a New Drug Application (NDA) has been submitted to the FDA seeking approval of Luveniq (LX211, voclosporin capsules) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.
September 09, 2009
The FDA has approved Bepreve (bepotastine besilate ophthalmic solution, from ISTA Pharmaceuticals), a histamine H1 receptor antagonist, for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.
August 11, 2009
Schering-Plough has expanded the Claritin product line with the introduction of Claritin Eye (ketotifen ophthalmic solution), an antihistamine eye drop that relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander for up to 12 hours.